MarketCap
Facebook
X
Telegram
Raytheon Technologies Corporation Financial Ratios 2025-2006 | RTX
Brief overview of Raytheon Technologies Corporation's valuation multiples
The review covers five available annual periods spanning 2021 to 2025.
The valuation comparison uses P/E 39.65x (median 36.31x), EV/EBITDA 21.7x (median 9.34x), P/S 3.01x (median 2.03x). Valuation is 48.1% above five-year reference levels. The premium requires support from earnings and returns.
The inverse P/E implies an earnings yield of 2.5%. This is not a dividend yield, but current earnings relative to market price.
Current measures of operating quality are ROE 10.3%, ROA 3.9%, ROCE 14.3%. Quality ratios send a mostly positive signal: resources are productive, with room for improvement.
On PEG (1.65x), valuation is stretched relative to growth and requires strong execution.
The cash return period is stable at 53.6 days initially and 52.9 days at the end.
Conclusion
Raytheon Technologies Corporation combines strong efficiency with demanding valuation. The cushion depends on continued earnings growth.
Annual Financial Ratios Raytheon Technologies Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
39.7 | 36.3 | 41.3 | 26.2 | 33.1 | -25.7 | 15.0 | 11.4 | 14.9 | 11.1 | 6.3 | 10.4 | 11.4 | 9.8 | 8.8 | 8.6 | 8.3 | 8.9 | 10.2 | - |
P/S |
3.0 | 2.1 | 1.9 | 2.0 | 2.0 | 1.6 | 1.1 | 0.9 | 1.1 | 1.0 | 0.9 | 1.0 | 1.0 | 0.9 | 0.7 | - | 0.6 | 0.7 | 0.8 | - |
EPS |
5.0 | 3.6 | 2.2 | 3.5 | 2.6 | -2.6 | 6.5 | 6.6 | 5.8 | 6.2 | 8.7 | 6.9 | 6.3 | 5.7 | 5.6 | 4.8 | 4.2 | 5 | 4.4 | - |
EV (Enterprise Value) |
363 B | 269 B | 226 B | 215 B | 207 B | 170 B | 173 B | 150 B | 124 B | 110 B | 99.7 B | 118 B | 122 B | 113 B | 81.8 B | 73.6 B | 66.3 B | 81.7 B | 42.9 B | - |
EBITDA per Share |
10.2 | 8.18 | 5.45 | 6.51 | 6.46 | 4.02 | 14.9 | 13.7 | 13.7 | 12.4 | 10.5 | 13 | 12.2 | 10.3 | 10.6 | 9.03 | 8.32 | 9.42 | 8.53 | - |
EV/EBITDA |
26.6 | 24.6 | 29.0 | 22.4 | 21.7 | 20.8 | 9.3 | 9.0 | 8.0 | 7.2 | 6.7 | 6.8 | 7.3 | 7.5 | 5.1 | 9.0 | 8.7 | 9.2 | 5.2 | - |
PEG |
1.65 | 8.12 | -10.78 | -52.04 | 23.04 | 0.16 | -9.85 | 0.8 | -2.19 | -0.38 | 0.24 | 1.16 | 1.05 | 3.64 | 0.55 | - | - | - | - | - |
P/B |
4.0 | 2.8 | 2.1 | 1.8 | 1.7 | 1.3 | 2.0 | 1.6 | 2.3 | 2.0 | 1.8 | 2.1 | 2.0 | 1.9 | 2.0 | 1.7 | 1.5 | 2.5 | - | - |
P/CF |
25.3 | 24.2 | 16.7 | 19.0 | - | 55.2 | 13.2 | 14.9 | 21.0 | 31.3 | 11.4 | 12.9 | 14.6 | 13.5 | 7.8 | 6.6 | 6.0 | 6.8 | 8.1 | - |
ROE % |
10.32 | 7.94 | 5.34 | 7.16 | 5.18 | -4.88 | 13.25 | 13.70 | 15.37 | 18.33 | 27.81 | 19.93 | 17.95 | 19.80 | 22.76 | 20.45 | 19.08 | 29.75 | 19.14 | - |
ROA % |
3.94 | 2.93 | 1.97 | 3.27 | 2.39 | -2.17 | 3.96 | 3.93 | 4.70 | 5.64 | 8.70 | 6.81 | 6.31 | 5.74 | 8.10 | 7.48 | 6.87 | 8.25 | - | - |
ROCE % |
14.25 | 10.87 | 5.96 | 7.58 | 6.88 | 1.02 | 8.53 | 8.32 | 11.96 | 12.05 | 11.24 | 14.28 | 13.58 | 11.71 | 18.91 | 32.26 | 31.78 | 47.64 | 31.95 | - |
Current Ratio |
1.6 | 1.6 | 1.6 | 1.9 | 1.9 | 1.2 | 1.1 | 1.1 | 1.3 | 1.3 | 1.2 | 1.3 | 1.3 | 1.2 | 1.4 | 1.6 | 1.6 | 1.4 | - | - |
DSO |
52.9 | 49.3 | 52.8 | 51.1 | 53.6 | 123.7 | 83.9 | 97.5 | 76.8 | 73.2 | 69.3 | 74.3 | 78.2 | 80.4 | 59.9 | - | 61.9 | 29.0 | - | - |
DIO |
- | - | - | - | - | 71.5 | 70.0 | 73.6 | 82.1 | 76.6 | 73.4 | 75.9 | 83.2 | 82.6 | 67.5 | - | - | - | - | - |
DPO |
- | - | - | - | - | 65.6 | 69.1 | 80.9 | 79.5 | 65.9 | 62.1 | 53.6 | 56.1 | 55.7 | 48.2 | - | - | - | - | - |
Operating Cycle |
52.9 | 49.3 | 52.8 | 51.1 | 53.6 | 195.2 | 153.9 | 171.1 | 158.9 | 149.8 | 142.8 | 150.2 | 161.4 | 163.0 | 127.4 | - | 61.9 | 28.9 | - | - |
Cash Conversion Cycle |
52.9 | 49.3 | 52.8 | 51.1 | 53.6 | 129.6 | 84.8 | 90.2 | 79.3 | 84.0 | 80.7 | 96.6 | 105.3 | 107.3 | 79.2 | - | 61.9 | 28.9 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Raytheon Technologies Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.58 | 1.53 | 1.43 | 1.24 | 1.15 | 1.1 | 0.08 | 1.29 | -0.68 | 0.91 | 0.98 | - | 0.94 | 0.88 | 0.73 | - | 0.93 | 0.69 | 0.5 | 0.09 | 0.17 | -2.55 | -0.1 | 1.33 | 1.34 | 2.22 | 1.58 | 0.83 | 1.56 | 2.59 | 1.64 | 0.5 | 1.69 | 1.83 | 1.75 | 1.26 | 1.8 | 1.67 | 1.43 | 3.86 | 1.55 | 1.76 | 1.6 | 1.64 | 2.07 | 1.87 | 1.35 | 1.62 | 1.59 | 1.73 | 1.4 | 2.28 | 1.58 | 1.49 | 0.37 | 1.49 | 1.49 | 1.48 | 1.13 | 1.32 | 1.22 | 0.95 | 1.15 | 1.06 |
EBITDA per Share |
2.88 | 2.69 | 2.69 | 2.4 | 2.31 | 2.34 | 1.2 | 2.2 | -0.59 | 1.37 | 1.86 | - | 1.37 | 1.23 | 1.41 | - | 3.18 | 1.25 | 1.41 | - | 0.74 | 1.32 | 2.36 | - | 4.04 | 7.31 | 2.44 | - | 4.55 | 5.12 | 3.18 | - | 4.58 | 4.06 | 3.35 | - | 4.51 | 3.99 | 2.92 | - | 4.23 | 3.8 | 2.97 | - | 4.42 | 3.66 | 2.85 | - | 4.11 | 3.76 | 2.72 | - | 3.45 | 3.14 | 2.28 | - | 3.5 | 3.12 | 2.23 | 3.26 | 2.85 | 2.04 | 0.92 | 1.12 |
ROE % |
11.96 | 11.16 | 10.40 | 7.61 | 7.70 | 3.90 | 3.35 | 5.08 | 4.26 | 7.45 | 7.13 | 5.21 | 7.12 | 6.64 | 5.88 | 4.41 | 4.60 | 3.05 | -3.71 | -4.88 | -2.33 | 0.05 | 9.92 | 13.25 | 12.30 | 12.77 | 13.55 | 13.70 | 13.26 | 14.53 | 14.07 | 15.37 | 17.71 | 18.58 | 18.72 | 18.33 | 26.64 | 26.25 | 26.89 | 27.81 | 20.55 | 21.51 | 21.25 | 19.93 | 19.80 | 18.35 | 17.87 | 17.95 | 21.30 | 22.27 | 22.50 | 19.80 | 17.91 | 18.51 | 19.40 | 22.76 | 22.34 | 21.85 | 20.17 | 21.27 | 21.24 | 4.34 | 5.72 | 5.62 |
ROA % |
4.57 | 4.27 | 3.95 | 2.88 | 2.96 | 1.42 | 1.35 | 2.16 | 1.97 | 3.26 | 3.32 | 2.43 | 3.08 | 2.21 | 2.68 | 2.00 | 2.08 | 1.36 | -1.65 | -2.17 | -1.43 | -0.78 | 2.95 | 3.97 | 3.66 | 3.76 | 3.92 | 3.93 | 3.82 | 4.27 | 4.23 | 4.70 | 5.42 | 5.69 | 5.75 | 5.64 | 8.25 | 8.16 | 8.39 | 8.70 | 6.56 | 7.04 | 7.12 | 6.81 | 6.81 | 6.36 | 6.25 | 6.31 | 7.00 | 7.00 | 6.77 | 5.74 | 5.59 | 6.17 | 6.82 | 8.10 | 7.92 | 7.67 | 7.01 | 7.20 | 6.95 | 1.48 | 1.84 | 1.73 |
ROCE % |
15.44 | 14.42 | 13.79 | 10.75 | 10.33 | 5.15 | 3.94 | 5.34 | 4.44 | 8.28 | 7.73 | 5.46 | 7.30 | 6.98 | 6.52 | 5.06 | 5.25 | 0.79 | -0.81 | -0.43 | 1.66 | 7.70 | 19.27 | 20.21 | 22.70 | 26.76 | 20.01 | 17.28 | 24.14 | 26.67 | 26.43 | 21.41 | 29.57 | 31.18 | 30.93 | 23.69 | 32.10 | 32.77 | 32.27 | 25.22 | 33.59 | 32.72 | 30.61 | 22.63 | 30.06 | 29.56 | 28.31 | 21.59 | 29.46 | 30.45 | 29.19 | 22.89 | 32.73 | 34.68 | 33.98 | 27.37 | 36.54 | 36.37 | 34.25 | 36.11 | 36.36 | 7.70 | 9.58 | 9.42 |
Current Ratio |
1.6 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.8 | 1.8 | 1.9 | 1.9 | 1.8 | - | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.5 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | 1.4 | 1.4 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 |
DSO |
49.6 | 53.3 | 51.2 | 50.3 | 48.4 | 46.2 | 47.5 | 48.1 | 67.6 | 49.8 | 50.8 | - | 24.9 | 25.4 | 54.4 | - | 51.9 | 54.4 | 57.7 | 51.4 | 14.9 | 51.4 | 72.3 | 68.2 | 70.2 | 86.9 | 96.3 | 107.6 | 154.8 | 156.3 | 80.4 | 73.3 | 76.3 | 75.2 | 79.5 | 71.5 | 73.0 | 70.4 | 75.6 | 68.0 | 70.5 | 66.2 | 72.3 | 63.6 | 68.0 | 60.1 | 70.5 | 62.4 | 67.6 | 65.3 | 71.5 | 61.6 | 67.3 | 73.3 | 75.9 | 60.6 | 61.2 | 60.2 | 65.8 | 59.4 | 57.9 | 64.9 | 57.9 | - |
Operating Cycle |
- | 53.3 | 51.2 | 50.3 | 48.4 | 46.2 | 47.5 | 48.1 | 67.6 | 49.8 | 50.8 | - | 24.9 | 25.4 | 54.4 | - | 51.9 | 54.4 | 57.7 | 51.4 | 14.9 | 51.4 | 72.3 | 68.2 | 70.2 | 86.9 | 96.3 | 107.6 | 154.8 | 156.3 | 80.4 | 73.3 | 76.3 | 75.2 | 79.5 | 71.5 | 73.0 | 70.4 | 75.6 | 68.0 | 70.5 | 66.2 | 72.3 | 63.6 | 68.0 | 60.1 | 70.5 | 62.4 | 67.6 | 65.3 | 71.5 | 61.6 | 67.3 | 73.3 | 75.9 | 60.6 | 61.2 | 60.2 | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 53.3 | 51.2 | 50.3 | 48.4 | 46.2 | 47.5 | 48.1 | 67.6 | 49.8 | 50.8 | - | 24.9 | 25.4 | 54.4 | - | 51.9 | 54.4 | 57.7 | 51.4 | 14.9 | 51.4 | 72.3 | 68.2 | 70.2 | 86.9 | 96.3 | 107.6 | 154.8 | 156.3 | 80.4 | 73.3 | 76.3 | 75.2 | 79.5 | 71.5 | 73.0 | 70.4 | 75.6 | 68.0 | 70.5 | 66.2 | 72.3 | 63.6 | 68.0 | 60.1 | 70.5 | 62.4 | 67.6 | 65.3 | 71.5 | 61.6 | 67.3 | 73.3 | 75.9 | 60.6 | 61.2 | 60.2 | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Raytheon Technologies Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
Bermuda
China
Canada
Israel
Brasil
